Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin
- PMID: 2969108
- PMCID: PMC281718
- DOI: 10.1073/pnas.85.14.5210
Efficacy of a cell-mediated reaction to the purified protein derivative of tuberculin in the disposal of Mycobacterium leprae from human skin
Abstract
The purpose of this study was to evaluate the effects of a delayed-type cell-mediated immune response to Mycobacterium tuberculosis antigen on the Mycobacterium leprae load in the skin of leprosy patients. Twelve patients with the lepromatous form of leprosy have been injected intradermally with 5 units of the purified protein derivative of tuberculin (PPD). Ten individuals responded with areas of induration ranging from 12 to 21 mm in diameter, and two were unresponsive (less than 10 mm). Twenty-one days thereafter, the injected and control sites were biopsied, and the histology, number of acid-fast bacilli, nature and phenotype of the emigrant cells, and ultrastructural characteristics of the lesions were evaluated. Eight of the 10 responding patients showed reductions in the number of acid-fast bacilli by factors ranging from 5 to 10,000. Two responders and both nonresponders exhibited no discernible decline in the number of organisms. The reduction in bacillary load was correlated with an intense mononuclear cell infiltrate, the maintenance of a high CD4+ T-cell/CD8+ T-cell ratio, the formation of granulomata, and the extensive destruction of previously parasitized macrophages.
Similar articles
-
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.J Exp Med. 1989 Mar 1;169(3):893-907. doi: 10.1084/jem.169.3.893. J Exp Med. 1989. PMID: 2494293 Free PMC article.
-
The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients.J Exp Med. 1988 Nov 1;168(5):1811-24. doi: 10.1084/jem.168.5.1811. J Exp Med. 1988. PMID: 3053962 Free PMC article.
-
The efficacy of a cell-mediated reaction in the disposal of M. leprae in human skin.Immunol Lett. 1988 Nov;19(3):223-7. doi: 10.1016/0165-2478(88)90146-0. Immunol Lett. 1988. PMID: 3069709
-
Reactions in leprosy.Lepr Rev. 1983 Jun;Spec No:61-7. doi: 10.5935/0305-7518.19830049. Lepr Rev. 1983. PMID: 6224993 Review. No abstract available.
-
A review of immunopathologic studies of human leprosy lesions in situ.Hawaii Med J. 1988 Feb;47(2):54-8. Hawaii Med J. 1988. PMID: 3284839 Review. No abstract available.
Cited by
-
Lysis of human macrophages by cytolytic CD4+ T cells fails to affect survival of intracellular Mycobacterium bovis-bacille Calmette-Guérin (BCG).Clin Exp Immunol. 1995 Jan;99(1):82-9. doi: 10.1111/j.1365-2249.1995.tb03476.x. Clin Exp Immunol. 1995. PMID: 7813114 Free PMC article.
-
T-cell-mediated cytotoxicity against Mycobacterium antigen-pulsed autologous macrophages in leprosy patients.Infect Immun. 1992 Aug;60(8):3389-95. doi: 10.1128/iai.60.8.3389-3395.1992. Infect Immun. 1992. PMID: 1639507 Free PMC article.
-
Widespread intradermal accumulation of mononuclear leukocytes in lepromatous leprosy patients treated systemically with recombinant interferon gamma.J Exp Med. 1990 Nov 1;172(5):1509-12. doi: 10.1084/jem.172.5.1509. J Exp Med. 1990. PMID: 2121891 Free PMC article.
-
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.J Exp Med. 1989 Mar 1;169(3):893-907. doi: 10.1084/jem.169.3.893. J Exp Med. 1989. PMID: 2494293 Free PMC article.
-
Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.J Exp Med. 1992 Jun 1;175(6):1717-28. doi: 10.1084/jem.175.6.1717. J Exp Med. 1992. PMID: 1588289 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials